New research comparing platelet rich plasma to steroid injection for tennis elbow
Data was released from Krakow Poland at the International Meeting on the use of Autologous Growth Factors in Orthopaedics and Sports Medicine: “State of the Art” – Krakow, Poland – 24 April 2009. The study found that patients receiving cortisone showed a 40% improvement compared to PRP 75% at 12 months. This is the first head to head study. Cortisone is well known to carry a risk of weakening & rupturing a tendon & is often discouraged.
We are conducting a multicenter FDA approved trial on tennis elbow beginning Mid June 2009.
Back to blog